| Literature DB >> 9260728 |
E Miyawaki1, Y Meah, W C Koller.
Abstract
We review recent reports suggesting that use of selective serotonergic agents that either inhibit synaptic reuptake or have specific serotonin receptor affinities may benefit a variety of motor disturbances in Parkinson's disease. The complex, mixed motoric effects of these agents in Parkinson's disease have not allowed for a consistent view on the interrelationship between dopamine and serotonin (5HT) in motor control but may speak to the nature of dysregulated neurotransmission in the disease.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9260728 DOI： 10.1097/00002826-199708000-00002
Source DB: PubMed Journal: Clin Neuropharmacol ISSN： 0362-5664 Impact factor: 1.592